New Report – The French Pharma Market 2022 - 2027 – Strategic Implications for pharma companies

We have just published a new 320-slide report?in English?which:

• Provides a?documented, detailed?and?robust?analysis of the?French pharma market?and of the?latest measures introduced by?health authorities, until March 6, 2023.
• Reviews the current?positions?of the various?stakeholders?and evaluates their likely?evolutions?by?2027.
• Estimates the?impact?of these?evolutions on the?pharma market?by?2027.
• Deduces?strategic implications?for?pharma companies...
• ... and possibe strategic decisions.

We are pleased to offer you a booklet?containing?excerpts?from this report, which is available by clicking on this link.

For any purchase?(link to order form), you will get:

• The?PowerPoint slide kit from which charts and data can be extracted.
• A workshop meeting of ~2 hours (possibility of face-to-face meeting in Paris area).

46 pharma companies have acquired, in the past, the previous editions of this report:

We can?help?you through:

• Consulting projects (e.g. support to strategic plan crafting at corporate, affiliate or franchise level).
• Seminars?(e.g. review and assessment of the main strategic trends at national and international level).
• Trainings?(e.g. intra- or inter-company master classes).

Feel free to contact us for more information.

Best regards,